Immediate Impact
12 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Sarcopenia
2024 Standout
Works of Weiping Ma being referenced
Comparative assessment of standard and immune response criteria for evaluation of response to PD-1 monotherapy in unresectable HCC
2021
Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Weiping Ma | 11 | 21 | 5 | 15 | 14 | 11 | 70 | |
| Pek Kei Im | 10 | 21 | 6 | 27 | 11 | 166 | ||
| Bagas Suryo Bintoro | 4 | 16 | 2 | 10 | 8 | 16 | 84 | |
| Jennifer L. Halford | 29 | 16 | 10 | 4 | 21 | 8 | 169 | |
| Angelo Gambi | 22 | 19 | 7 | 5 | 33 | 10 | 180 | |
| Joshua Au Yeung | 16 | 16 | 42 | 8 | 6 | 10 | 167 | |
| Jianrong Jin | 7 | 5 | 2 | 20 | 13 | 78 | ||
| Alessio Lachi | 5 | 5 | 2 | 4 | 33 | 16 | 89 | |
| Aude Richard | 8 | 10 | 5 | 5 | 2 | 12 | 90 | |
| Tejinder Rakhra-Burris | 12 | 21 | 3 | 4 | 9 | 121 | ||
| Misha Kabir | 14 | 18 | 3 | 1 | 7 | 16 | 171 |
All Works
Login with ORCID to disown or claim papers
Loading papers...